PDS Pathology Data Systems AG sold to Instem plc

31 August 2021

Instem plc, a leading provider of IT solutions and services to the global life sciences market, listed at the Alternative Investment Market (AIM) of the London Stock Exchange (LSE), has acquired its Swiss competitor PDS Pathology Data Systems AG, with offices in the United States and Japan, providing software and outsourced services for non-clinical study management and regulatory submissions, at an enterprise value of CHF 14.25m. The transaction closed on 31 August 2021.

VISCHER advised the selling PDS shareholders in this transaction. The VISCHER team led by partner Dr. Robert Bernet (Corporate/M&A) comprised Dr. Peter Kühn (Counsel, Corporate/M&A), Ruben Masar (Managing Associate, Corporate/M&A), Christoph Niederer (Partner, Tax) and Veysel Oruclar (Associate, Tax).

Press release
Youtube video